跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Aezar - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Aezar
Approved
STANDARD
Aezar
Zeiss Pharmaceuticals Pvt. Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8250bff706f58a10
Company
Zeiss Pharmaceuticals Pvt. Limited
Type
Standard
Approval Details
Approval Id
8250bff706f58a10
Drug Approval Philippines Name
Aezar
Product Name
Aezar
Registration Number
DRP-5515-02
Brand Name
Aezar
Generic Name
Piperacillin (as sodium) / Tazobactam (as sodium)
Dosage Form
Powder for Injection (IV)
Dosage Strength
2 g/250 mg
Manufacturer
Zeiss Pharmaceuticals Pvt. Limited
Importer
Ambica International Corporation
Distributor
Dynasty Pharmaceuticals
Issuance Date
29 March 2024
Expiry Date
12 November 2029
Pharmacologic Category
Antibacterial
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8250bff706f58a10
Type
Standard
Back to Philippines FDA Approvals